Anatomic Pathology Market Size and Forecast (2021 – 2031)
Anatomic Pathology Market Size and Forecast (2021 – 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product and Services [Services (Histopathology and Cytopathology), Instruments (Microtomes and Cryostat, Automatic Stainers, Tissue Processors, and Others), and Consumables], Application (Disease Diagnosis, Drug Discovery and Development, and Others), End User (Hospitals, Research Laboratories, Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
$3,633 – $6,433
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Anatomical pathology is the study of organs and tissues to determine the causes and effects of particular diseases. Anatomic (or anatomical) pathology is the branch of medicine that studies the effect of disease on the structure of body organs, both as a whole (grossly) and microscopically. The primary role of anatomic pathology is to identify abnormalities that can help to diagnose disease and manage treatment. Although one of the frequent uses of anatomic pathology is to help identify and manage various types of tumors or cancers, it is also valuable in evaluating other conditions, including kidney and liver diseases, autoimmune disorders, and infections, for example.
North America accounted for a major share of the global anatomic pathology market in 2023. The North America anatomic pathology market is segmented into the US, Canada, and Mexico.
In the US, cancer has a significant impact on society. A few common cancer types in the country are breast cancer, lung and bronchus cancer, prostate cancer, colon and rectum cancer, and liver cancer. As per the National Cancer Institute, in 2021, ~17.43 individuals were living with cancer at any site in the US. The number of cancer survivors is projected to reach 22.2 million by 2030. This mounting prevalence of cancer cases is expected to increase the demand for pathologic diagnostic tests such as biopsies, fine-needle aspiration (FNA), genetic testing, and other novel techniques. Moreover, there has been unprecedented growth in innovative and improved medical technologies in the US in recent years. This growth resulted in the development of advanced medical devices in the healthcare industry. Players operating in the US anatomic pathology market continuously focus on the development of innovative and convenient instruments and consumables for pathological procedures. In November 2023, Illumina Inc., US, a global leader in DNA sequencing and array-based technologies, introduced TruSight Oncology 500 ctDNA v2 (plate number 1 ctDNA v2), a new version of its distributed liquid biopsy assay that allows comprehensive noninvasive genomic profiling of circulating tumor DNA from blood, complementing tissue-based testing. In 2020, F. Hoffmann-La Roche received the US Food and Drug Administration (FDA) approval for the expanded use of the CINtec PLUS Cytology test to aid clinicians in preventing cervical cancer. Thus, factors such as the high prevalence of cancer, strong presence of some major players, and availability of high-quality infrastructure for hospitals and clinical laboratories bolster the growth of the anatomic pathology market in the US.
Governments and private agricultural associations are highly focused on advancements in crop genomics to improve the characteristics of crops. The Agricultural Genome to Phenome Initiative (AG2PI) of the National Institute of Food and Agriculture focuses on collaborative engagements to develop a community of researchers studying both crop and animal genetics, which would lay the foundation for expanding knowledge about genomes and phenomes that are important to the agriculture sector in the US. The initiative is likely to result in the development of approaches to understanding how variable weather, environments, and production systems impact genetic diversity in crops and animals. Thus, the rising number of initiatives taken to foster studies related to the genetic makeup of crops for yield and quality improvement are likely to favor the anatomic pathology market in the US in the future.
Growing Focus on Personalized Medicines to Provide Market Opportunities in Future
Personalized medicines are mainly designed by considering individuals’ genetic profiles to guide the decisions made with respect to the prevention, diagnosis, and treatment of a disease. They provide an opportunity for drug manufacturers to develop agents that target patient groups that do not respond to medications as intended or for them who do not respond as expected to traditional healthcare practices. There is much evidence indicating that a substantial portion of the variability in drug response depends on factors that are genetically controlled, including age, nutrition, environmental exposure, and health status. Genomics plays an important role in the emergence of personalized medicines, as having the knowledge of a patient’s genetic profile would help doctors in selecting an apt medication. Personalized medicines are helpful in improving healthcare by enabling each patient to receive earlier diagnoses, risk assessments, and optimal treatments.
Pathologists play an important role in developing and implementing molecular and genomic tests in practice. Personalized medicines are used in the treatment of diseases such as breast cancer and cardiovascular diseases. Personalized anticancer medicines exhibit fewer and less severe side effects than other types of treatment as they are designed for more specific action. Further, with the ongoing progress in research and clinical studies, personalized medicines are likely to reach even greater potential to improve the quality of patient care. Thus, the growing focus on personalized medicines is expected to boost the anatomic pathology market growth.
Anatomic Pathology Market: Competitive Landscape and Key Developments
F. Hoffmann-La Roche Ltd, Beckman Coulter Inc, Hologic Inc, Agilent Technologies Inc, BioGenex Laboratories Inc, Diapath S.p.A., Bio SB, Merck KGaA, BD, and PHC Holdings Corporation are among the key companies operating in the anatomic pathology market.
The US Food and Drug Administration, Centers for Disease Control and Prevention (CDC), and Organisation for Economic Co-operation and Development are among the primary and secondary sources referred to while preparing the anatomic pathology market report.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Geographical coverage: | |
| Year of Publication: |
According to our new research study on “Anatomic Pathology Market Forecast to 2031 – Global Analysis – by Products and Services, Application, End User, and Geography,” the market was valued at US$ 30.22 billion in 2023 and is projected to reach US$ 53.27 billion by 2031; it is expected to register a CAGR of 7.3% during 2023–2031. The increase in the prevalence of cancer and kidney diseases and the rise in the number of strategic initiatives are contributing to the anatomic pathology market growth. However, the shortage of skilled professionals and stringent government regulations hamper the market growth. Further, the integration of artificial intelligence and machine learning is expected to bring new anatomic pathology market trends in the coming years.
Digital pathology, a growing subfield within anatomical pathology, uses digital technologies to streamline data collection and management. It helps reduce risks to specimen samples and has the potential to accelerate enrolment in clinical trials. Additionally, digital pathology can reduce sample-to-result turnaround time and streamline the central pathology review process, further offering opportunities to increase trial efficiency.
To introduce upgraded technologies, machine learning (ML) and artificial intelligence (AI) are integrated with digital pathology for proper analysis and management of data. Several anatomic pathology laboratories are becoming increasingly aware of the benefits of digitization and AI in practice. Moreover, recent technological advancements and regulatory approvals are encouraging the digitalization of laboratory operations to improve the speed and accuracy of processes. With AI and ML, pathologists will have an augmented ability to improve diagnostic accuracy, efficiency, and consistency.
In November 2023, Dedalus Group and Ibex Medical Analytics launched a fully integrated End-to-End AI-powered Digital Pathology Solution for cancer diagnostics. It enables complete digitization of anatomic pathology labs with a next-generation Anatomic Pathology Information System (AIS) and DP solution, harnessing the power of data and AI for assisted case prioritization, advanced image analysis, and reproducible diagnoses. The rising focus on integrating AI technology for anatomical pathology processes due to its benefits is expected to act as a trend and is expected to fuel the growth of the market in the forecast period.
Based on products and services, the anatomic pathology market is segmented into instruments, consumables, and services. The services segment is further bifurcated into histopathology and cytopathology. The instruments segment is further divided into microtomes and cryostat, automatic stainers, tissue processors, and others. The instruments segment held the largest market share in 2023. The instruments that are used in anatomic pathology practices include basic pathology equipment such as microtome, a tool to cut extremely thin sections for materials such as bones, minerals, and teeth; an automatic slide stainer that highlights the structures in biological tissues and provides a more detailed look at the sample; biomedical specimen cabinets that are used as storage systems to organize the supply of laboratories; cooling plate; paraffin trimmer/dispenser; and slide dryer. Microtome is used as an alternative to electropolishing and ion milling. Tissue processing systems that are used in anatomic pathology include tissue embedding systems, tissue floating systems, tissue processors, and tissue water bath instruments. Apart from these, many more advanced and automated devices are used in anatomic pathology, which vary from process to process, depending upon the test to be performed for diagnosis. These machines are complex to handle, and thus, proper training is required to perform tasks as per the requirements of the planned experiments. The growing adoption of automation is expected to boost the market for anatomic pathology instruments during the forecast period.
By application, the market is segmented into disease diagnosis, drug discovery and development, and others. The disease diagnosis segment held the largest market share in 2023.
Based on end user, the anatomic pathology market is divided into hospitals, research laboratories, diagnostic laboratories, and others. The hospitals segment held the largest market share in 2023. Hospitals account for the largest share of the anatomic pathology market due to the increasing prevalence of chronic illnesses, which require advanced diagnostic tests and tools, long-term care, and regular monitoring. Anatomic pathology majorly involves necropsy, cytopathology, histopathology, immunopathology, and cytopathology techniques. All these fields are related to the diagnosis and treatment of severe chronic diseases such as heart disease, cancer, and tumors. Anatomic pathology is also used in the study of kidney and liver diseases, autoimmune disorders, and infections. An increase in the number of hospitals and critical care centers, along with a rise in government initiatives for improving healthcare services, is projected to fuel the use of anatomical pathology equipment and services in hospitals.
F. Hoffmann-La Roche Ltd, Beckman Coulter Inc, Hologic Inc, Agilent Technologies Inc, BioGenex Laboratories Inc, Diapath S.p.A., Bio SB, Merck KGaA, BD, and PHC Holdings Corporation are among the leading companies operating in the global anatomic pathology market.
Companies operating in the anatomic pathology market adopt various organic and inorganic strategies. Organic strategies mainly include product launches and product approvals. Acquisitions, collaborations, and partnerships are among the inorganic growth strategies witnessed in the anatomic pathology market. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, thereby contributing to the overall anatomic pathology market growth. Further, acquisition and partnership strategies help them strengthen their customer base and expand their product portfolios.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the anatomic pathology market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth market trends and outlook coupled with the factors driving the anatomic pathology market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.
1. Introduction
1.1 The the Reporting Teams Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4. Anatomic Pathology Market Landscape
4.1 Overview
4.2 PEST Analysis
5. Anatomic Pathology Market – Key Market Dynamics
5.1 Anatomic Pathology Market – Key Market Dynamics
5.2 Market Drivers
5.2.1 Increase in Prevalence of Cancer and Kidney Diseases
5.2.2 Rise in Number of Strategic Initiatives
5.3 Market Restraints
5.3.1 Lack of Skilled Professionals
5.3.2 Stringent Government Regulations
5.4 Market Opportunities
5.4.1 Growing Focus on Personalized Medicines
5.5 Future Trends
5.5.1 Integration of Artificial Intelligence and Machine Learning
5.6 Impact of Drivers and Restraints:
6. Anatomic Pathology Market – Global Market Analysis
6.1 Anatomic Pathology Market Revenue (US$ Million), 2021–2031
6.2 Anatomic Pathology Market Forecast Analysis
7. Anatomic Pathology Market Analysis – by Product and Services
7.1 Services
7.1.1 Overview
7.1.2 Services: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Instruments
7.2.1 Overview
7.2.2 Instruments: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Consumables
7.3.1 Overview
7.3.2 Consumables: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
8. Anatomic Pathology Market Analysis – by Application
8.1 Disease Diagnosis
8.1.1 Overview
8.1.2 Disease Diagnosis: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
8.2 Drug Discovery and Development
8.2.1 Overview
8.2.2 Drug Discovery and Development: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
8.3 Others
8.3.1 Overview
8.3.2 Others: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
9. Anatomic Pathology Market Analysis – by End User
9.1 Hospitals
9.1.1 Overview
9.1.2 Hospitals: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
9.2 Research Laboratories
9.2.1 Overview
9.2.2 Research Laboratories: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
9.3 Diagnostic Laboratories
9.3.1 Overview
9.3.2 Diagnostic Laboratories: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
9.4 Others
9.4.1 Overview
9.4.2 Others: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
10. Anatomic Pathology Market – Geographical Analysis
10.1 Overview
10.2 North America
10.2.1 North America Anatomic Pathology Market Overview
10.2.2 North America: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
10.2.3 North America: Anatomic Pathology Market – Revenue and Forecast Analysis – by Product and Services
10.2.4 North America: Anatomic Pathology Market – Revenue and Forecast Analysis – by Services
10.2.5 North America: Anatomic Pathology Market – Revenue and Forecast Analysis – by Instruments
10.2.6 North America: Anatomic Pathology Market – Revenue and Forecast Analysis – by Application
10.2.7 North America: Anatomic Pathology Market – Revenue and Forecast Analysis – by End User
10.2.8 North America: Anatomic Pathology Market – Revenue and Forecast Analysis – by Country
10.2.8.1 United States: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
10.2.8.1.1 United States: Anatomic Pathology Market Breakdown, by Product and Services
10.2.8.1.1.1 United States: Anatomic Pathology Market Breakdown, by Services
10.2.8.1.1.2 United States: Anatomic Pathology Market Breakdown, by Instruments
10.2.8.1.2 United States: Anatomic Pathology Market Breakdown, by Application
10.2.8.1.3 United States: Anatomic Pathology Market Breakdown, by End User
10.2.8.2 Canada: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
10.2.8.2.1 Canada: Anatomic Pathology Market Breakdown, by Product and Services
10.2.8.2.1.1 Canada: Anatomic Pathology Market Breakdown, by Services
10.2.8.2.1.2 Canada: Anatomic Pathology Market Breakdown, by Instruments
10.2.8.2.2 Canada: Anatomic Pathology Market Breakdown, by Application
10.2.8.2.3 Canada: Anatomic Pathology Market Breakdown, by End User
10.2.8.3 Mexico: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
10.2.8.3.1 Mexico: Anatomic Pathology Market Breakdown, by Product and Services
10.2.8.3.1.1 Mexico: Anatomic Pathology Market Breakdown, by Services
10.2.8.3.1.2 Mexico: Anatomic Pathology Market Breakdown, by Instruments
10.2.8.3.2 Mexico: Anatomic Pathology Market Breakdown, by Application
10.2.8.3.3 Mexico: Anatomic Pathology Market Breakdown, by End User
10.3 Europe
10.3.1 Europe Anatomic Pathology Market Overview
10.3.2 Europe: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
10.3.3 Europe: Anatomic Pathology Market – Revenue and Forecast Analysis – by Product and Services
10.3.4 Europe: Anatomic Pathology Market – Revenue and Forecast Analysis – by Services
10.3.5 Europe: Anatomic Pathology Market – Revenue and Forecast Analysis – by Instruments
10.3.6 Europe: Anatomic Pathology Market – Revenue and Forecast Analysis – by Application
10.3.7 Europe: Anatomic Pathology Market – Revenue and Forecast Analysis – by End User
10.3.8 Europe: Anatomic Pathology Market – Revenue and Forecast Analysis – by Country
10.3.8.1 United Kingdom: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
10.3.8.1.1 United Kingdom: Anatomic Pathology Market Breakdown, by Product and Services
10.3.8.1.1.1 United Kingdom: Anatomic Pathology Market Breakdown, by Services
10.3.8.1.1.2 United Kingdom: Anatomic Pathology Market Breakdown, by Instruments
10.3.8.1.2 United Kingdom: Anatomic Pathology Market Breakdown, by Application
10.3.8.1.3 United Kingdom: Anatomic Pathology Market Breakdown, by End User
10.3.8.2 Germany: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
10.3.8.2.1 Germany: Anatomic Pathology Market Breakdown, by Product and Services
10.3.8.2.1.1 Germany: Anatomic Pathology Market Breakdown, by Services
10.3.8.2.1.2 Germany: Anatomic Pathology Market Breakdown, by Instruments
10.3.8.2.2 Germany: Anatomic Pathology Market Breakdown, by Application
10.3.8.2.3 Germany: Anatomic Pathology Market Breakdown, by End User
10.3.8.3 France: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
10.3.8.3.1 France: Anatomic Pathology Market Breakdown, by Product and Services
10.3.8.3.1.1 France: Anatomic Pathology Market Breakdown, by Services
10.3.8.3.1.2 rance: Anatomic Pathology Market Breakdown, by Instruments
10.3.8.3.2 France: Anatomic Pathology Market Breakdown, by Application
10.3.8.3.3 France: Anatomic Pathology Market Breakdown, by End User
10.3.8.4 Italy: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
10.3.8.4.1 Italy: Anatomic Pathology Market Breakdown, by Product and Services
10.3.8.4.1.1 Italy: Anatomic Pathology Market Breakdown, by Services
10.3.8.4.1.2 Italy: Anatomic Pathology Market Breakdown, by Instruments
10.3.8.4.2 Italy: Anatomic Pathology Market Breakdown, by Application
10.3.8.4.3 Italy: Anatomic Pathology Market Breakdown, by End User
10.3.8.5 Spain: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
10.3.8.5.1 Spain: Anatomic Pathology Market Breakdown, by Product and Services
10.3.8.5.1.1 Spain: Anatomic Pathology Market Breakdown, by Services
10.3.8.5.1.2 Spain: Anatomic Pathology Market Breakdown, by Instruments
10.3.8.5.2 Spain: Anatomic Pathology Market Breakdown, by Application
10.3.8.5.3 Spain: Anatomic Pathology Market Breakdown, by End User
10.3.8.6 Rest of Europe: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
10.3.8.6.1 Rest of Europe: Anatomic Pathology Market Breakdown, by Product and Services
10.3.8.6.1.1 Rest of Europe: Anatomic Pathology Market Breakdown, by Services
10.3.8.6.1.2 Rest of Europe: Anatomic Pathology Market Breakdown, by Instruments
10.3.8.6.2 Rest of Europe: Anatomic Pathology Market Breakdown, by Application
10.3.8.6.3 Rest of Europe: Anatomic Pathology Market Breakdown, by End User
10.4 Asia Pacific
10.4.1 Asia Pacific Anatomic Pathology Market Overview
10.4.2 Asia Pacific: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
10.4.3 Asia Pacific: Anatomic Pathology Market – Revenue and Forecast Analysis – by Product and Services
10.4.4 Asia Pacific: Anatomic Pathology Market – Revenue and Forecast Analysis – by Services
10.4.5 Asia Pacific: Anatomic Pathology Market – Revenue and Forecast Analysis – by Instruments
10.4.6 Asia Pacific: Anatomic Pathology Market – Revenue and Forecast Analysis – by Application
10.4.7 Asia Pacific: Anatomic Pathology Market – Revenue and Forecast Analysis – by End User
10.4.8 Asia Pacific: Anatomic Pathology Market – Revenue and Forecast Analysis – by Country
10.4.8.1 China: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
10.4.8.1.1 China: Anatomic Pathology Market Breakdown, by Product and Services
10.4.8.1.1.1 China: Anatomic Pathology Market Breakdown, by Services
10.4.8.1.1.2 China: Anatomic Pathology Market Breakdown, by Instruments
10.4.8.1.2 China: Anatomic Pathology Market Breakdown, by Application
10.4.8.1.3 China: Anatomic Pathology Market Breakdown, by End User
10.4.8.2 Japan: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
10.4.8.2.1 Japan: Anatomic Pathology Market Breakdown, by Product and Services
10.4.8.2.1.1 Japan: Anatomic Pathology Market Breakdown, by Services
10.4.8.2.1.2 Japan: Anatomic Pathology Market Breakdown, by Instruments
10.4.8.2.2 Japan: Anatomic Pathology Market Breakdown, by Application
10.4.8.2.3 Japan: Anatomic Pathology Market Breakdown, by End User
10.4.8.3 India: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
10.4.8.3.1 India: Anatomic Pathology Market Breakdown, by Product and Services
10.4.8.3.1.1 India: Anatomic Pathology Market Breakdown, by Services
10.4.8.3.1.2 India: Anatomic Pathology Market Breakdown, by Instruments
10.4.8.3.2 India: Anatomic Pathology Market Breakdown, by Application
10.4.8.3.3 India: Anatomic Pathology Market Breakdown, by End User
10.4.8.4 Australia: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
10.4.8.4.1 Australia: Anatomic Pathology Market Breakdown, by Product and Services
10.4.8.4.1.1 Australia: Anatomic Pathology Market Breakdown, by Services
10.4.8.4.1.2 Australia: Anatomic Pathology Market Breakdown, by Instruments
10.4.8.4.2 Australia: Anatomic Pathology Market Breakdown, by Application
10.4.8.4.3 Australia: Anatomic Pathology Market Breakdown, by End User
10.4.8.5 South Korea: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
10.4.8.5.1 South Korea: Anatomic Pathology Market Breakdown, by Product and Services
10.4.8.5.1.1 South Korea: Anatomic Pathology Market Breakdown, by Services
10.4.8.5.1.2 South Korea: Anatomic Pathology Market Breakdown, by Instruments
10.4.8.5.2 South Korea: Anatomic Pathology Market Breakdown, by Application
10.4.8.5.3 South Korea: Anatomic Pathology Market Breakdown, by End User
10.4.8.6 Rest of APAC: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
10.4.8.6.1 Rest of APAC: Anatomic Pathology Market Breakdown, by Product and Services
10.4.8.6.1.1 Rest of APAC: Anatomic Pathology Market Breakdown, by Services
10.4.8.6.1.2 Rest of APAC: Anatomic Pathology Market Breakdown, by Instruments
10.4.8.6.2 Rest of APAC: Anatomic Pathology Market Breakdown, by Application
10.4.8.6.3 Rest of APAC: Anatomic Pathology Market Breakdown, by End User
10.5 Middle East and Africa
10.5.1 Middle East and Africa Anatomic Pathology Market Overview
10.5.2 Middle East and Africa: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
10.5.3 Middle East and Africa: Anatomic Pathology Market – Revenue and Forecast Analysis – by Product and Services
10.5.4 Middle East and Africa: Anatomic Pathology Market – Revenue and Forecast Analysis – by Services
10.5.5 Middle East and Africa: Anatomic Pathology Market – Revenue and Forecast Analysis – by Instruments
10.5.6 Middle East and Africa: Anatomic Pathology Market – Revenue and Forecast Analysis – by Application
10.5.7 Middle East and Africa: Anatomic Pathology Market – Revenue and Forecast Analysis – by End User
10.5.8 Middle East and Africa: Anatomic Pathology Market – Revenue and Forecast Analysis – by Country
10.5.8.1 South Africa: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
10.5.8.1.1 South Africa: Anatomic Pathology Market Breakdown, by Product and Services
10.5.8.1.1.1 South Africa: Anatomic Pathology Market Breakdown, by Services
10.5.8.1.1.2 South Africa: Anatomic Pathology Market Breakdown, by Instruments
10.5.8.1.2 South Africa: Anatomic Pathology Market Breakdown, by Application
10.5.8.1.3 South Africa: Anatomic Pathology Market Breakdown, by End User
10.5.8.2 Saudi Arabia: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
10.5.8.2.1 Saudi Arabia: Anatomic Pathology Market Breakdown, by Product and Services
10.5.8.2.1.1 Saudi Arabia: Anatomic Pathology Market Breakdown, by Services
10.5.8.2.1.2 Saudi Arabia: Anatomic Pathology Market Breakdown, by Instruments
10.5.8.2.2 Saudi Arabia: Anatomic Pathology Market Breakdown, by Application
10.5.8.2.3 Saudi Arabia: Anatomic Pathology Market Breakdown, by End User
10.5.8.3 United Arab Emirates: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
10.5.8.3.1 United Arab Emirates: Anatomic Pathology Market Breakdown, by Product and Services
10.5.8.3.1.1 United Arab Emirates: Anatomic Pathology Market Breakdown, by Services
10.5.8.3.1.2 United Arab Emirates: Anatomic Pathology Market Breakdown, by Instruments
10.5.8.3.2 United Arab Emirates: Anatomic Pathology Market Breakdown, by Application
10.5.8.3.3 United Arab Emirates: Anatomic Pathology Market Breakdown, by End User
10.5.8.4 Rest of Middle East and Africa: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
10.5.8.4.1 Rest of Middle East and Africa: Anatomic Pathology Market Breakdown, by Product and Services
10.5.8.4.1.1 Rest of Middle East and Africa: Anatomic Pathology Market Breakdown, by Services
10.5.8.4.1.2 Rest of Middle East and Africa: Anatomic Pathology Market Breakdown, by Instruments
10.5.8.4.2 Rest of Middle East and Africa: Anatomic Pathology Market Breakdown, by Application
10.5.8.4.3 Rest of Middle East and Africa: Anatomic Pathology Market Breakdown, by End User
10.6 South and Central America
10.6.1 South and Central America Anatomic Pathology Market Overview
10.6.2 South and Central America: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
10.6.3 South and Central America: Anatomic Pathology Market – Revenue and Forecast Analysis – by Product and Services
10.6.4 South and Central America: Anatomic Pathology Market – Revenue and Forecast Analysis – by Services
10.6.5 South and Central America: Anatomic Pathology Market – Revenue and Forecast Analysis – by Instruments
10.6.6 South and Central America: Anatomic Pathology Market – Revenue and Forecast Analysis – by Application
10.6.7 South and Central America: Anatomic Pathology Market – Revenue and Forecast Analysis – by End User
10.6.8 South and Central America: Anatomic Pathology Market – Revenue and Forecast Analysis – by Country
10.6.8.1 Brazil: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
10.6.8.1.1 Brazil: Anatomic Pathology Market Breakdown, by Product and Services
10.6.8.1.1.1 Brazil: Anatomic Pathology Market Breakdown, by Services
10.6.8.1.1.2 Brazil: Anatomic Pathology Market Breakdown, by Instruments
10.6.8.1.2 Brazil: Anatomic Pathology Market Breakdown, by Application
10.6.8.1.3 Brazil: Anatomic Pathology Market Breakdown, by End User
10.6.8.2 Argentina: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
10.6.8.2.1 Argentina: Anatomic Pathology Market Breakdown, by Product and Services
10.6.8.2.1.1 Argentina: Anatomic Pathology Market Breakdown, by Services
10.6.8.2.1.2 Argentina: Anatomic Pathology Market Breakdown, by Instruments
10.6.8.2.2 Argentina: Anatomic Pathology Market Breakdown, by Application
10.6.8.2.3 Argentina: Anatomic Pathology Market Breakdown, by End User
10.6.8.3 Rest of South and Central America: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
10.6.8.3.1 Rest of South and Central America: Anatomic Pathology Market Breakdown, by Product and Services
10.6.8.3.1.1 Rest of South and Central America: Anatomic Pathology Market Breakdown, by Services
10.6.8.3.1.2 Rest of South and Central America: Anatomic Pathology Market Breakdown, by Instruments
10.6.8.3.2 Rest of South and Central America: Anatomic Pathology Market Breakdown, by Application
10.6.8.3.3 Rest of South and Central America: Anatomic Pathology Market Breakdown, by End User
11. Industry Landscape
11.1 Overview
11.2 Growth Strategies in Anatomic Pathology Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 F. Hoffmann-La Roche Ltd
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Beckman Coulter Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Hologic Inc
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Agilent Technologies Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 BioGenex Laboratories Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Diapath S.p.A.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Bio SB
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Merck KGaA
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 PHC Holdings Corporation
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms
Table 1. Anatomic Pathology Market Segmentation
Table 2. Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
Table 3. Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million) – by Product and Services
Table 4. Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million) – by Application
Table 5. Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 6. North America: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services
Table 7. North America: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 8. North America: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 9. North America: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 10. North America: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 11. United States: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services
Table 12. United States: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 13. United States: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 14. United States: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 15. United States: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 16. Canada: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services
Table 17. Canada: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 18. Canada: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 19. Canada: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 20. Canada: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 21. Mexico: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services
Table 22. Mexico: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 23. Mexico: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 24. Mexico: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 25. Mexico: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 26. Europe: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services
Table 27. Europe: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 28. Europe: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 29. Europe: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 30. Europe: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 31. United Kingdom: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services
Table 32. United Kingdom: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 33. United Kingdom: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 34. United Kingdom: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 35. United Kingdom: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 36. Germany: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services
Table 37. Germany: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 38. Germany: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 39. Germany: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 40. Germany: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 41. France: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services
Table 42. France: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 43. France: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 44. France: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 45. France: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 46. Italy: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services
Table 47. Italy: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 48. Italy: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 49. Italy: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 50. Italy: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 51. Spain: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services
Table 52. Spain: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 53. Spain: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 54. Spain: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 55. Spain: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 56. Rest of Europe: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services
Table 57. Rest of Europe: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 58. Rest of Europe: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 59. Rest of Europe: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 60. Rest of Europe: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 61. Asia Pacific: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services
Table 62. Asia Pacific: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 63. Asia Pacific: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 64. Asia Pacific: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 65. Asia Pacific: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 66. China: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services
Table 67. China: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 68. China: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 69. China: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 70. China: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 71. Japan: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services
Table 72. Japan: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 73. Japan: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 74. Japan: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 75. Japan: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 76. India: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services
Table 77. India: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 78. India: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 79. India: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 80. India: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 81. Australia: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services
Table 82. Australia: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 83. Australia: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 84. Australia: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 85. Australia: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 86. South Korea: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services
Table 87. South Korea: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 88. South Korea: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 89. South Korea: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 90. South Korea: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 91. Rest of APAC: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services
Table 92. Rest of APAC: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 93. Rest of APAC: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 94. Rest of APAC: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 95. Rest of APAC: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 96. Middle East and Africa: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services
Table 97. Middle East and Africa: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 98. Middle East and Africa: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 99. Middle East and Africa: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 100. Middle East and Africa: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 101. South Africa: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services
Table 102. South Africa: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 103. South Africa: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 104. South Africa: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 105. South Africa: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 106. Saudi Arabia: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services
Table 107. Saudi Arabia: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 108. Saudi Arabia: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 109. Saudi Arabia: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 110. Saudi Arabia: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 111. United Arab Emirates: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services
Table 112. United Arab Emirates: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 113. United Arab Emirates: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 114. United Arab Emirates: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 115. United Arab Emirates: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 116. Rest of Middle East and Africa: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services
Table 117. Rest of Middle East and Africa: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 118. Rest of Middle East and Africa: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 119. Rest of Middle East and Africa: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 120. Rest of Middle East and Africa: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 121. South and Central America: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services
Table 122. South and Central America: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 123. South and Central America: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 124. South and Central America: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 125. South and Central America: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 126. Brazil: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services
Table 127. Brazil: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 128. Brazil: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 129. Brazil: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 130. Brazil: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 131. Argentina: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services
Table 132. Argentina: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 133. Argentina: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 134. Argentina: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 135. Argentina: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 136. Rest of South and Central America: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services
Table 137. Rest of South and Central America: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 138. Rest of South and Central America: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 139. Rest of South and Central America: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 140. Rest of South and Central America: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 141. Recent Organic Growth Strategies in Anatomic Pathology Market
Table 142. Recent Inorganic Growth Strategies in the Anatomic Pathology Market
Table 143. Glossary of Terms, Anatomic Pathology Market
Figure 1. Anatomic Pathology Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Anatomic Pathology Market Revenue (US$ Million), 2021–2031
Figure 5. Anatomic Pathology Market Share (%) – by Product and Services (2023 and 2031)
Figure 6. Services: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
Figure 7. Instruments: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
Figure 8. Consumables: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
Figure 9. Anatomic Pathology Market Share (%) – by Application (2023 and 2031)
Figure 10. Disease Diagnosis: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
Figure 11. Drug Discovery and Development: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
Figure 12. Others: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
Figure 13. Anatomic Pathology Market Share (%) – by End User (2023 and 2031)
Figure 14. Hospitals: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
Figure 15. Research Laboratories: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
Figure 16. Diagnostic Laboratories: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
Figure 17. Others: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)
Figure 18. Anatomic Pathology Market Breakdown by Region, 2023 and 2031 (%)
Figure 19. North America: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)
Figure 20. North America: Anatomic Pathology Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 21. United States: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)
Figure 22. Canada: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)
Figure 23. Mexico: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)
Figure 24. Europe: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)
Figure 25. Europe: Anatomic Pathology Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 26. United Kingdom: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)
Figure 27. Germany: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)
Figure 28. France: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)
Figure 29. Italy: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)
Figure 30. Spain: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)
Figure 31. Rest of Europe: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)
Figure 32. Asia Pacific: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)
Figure 33. Asia Pacific: Anatomic Pathology Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 34. China: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)
Figure 35. Japan: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)
Figure 36. India: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)
Figure 37. Australia: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)
Figure 38. South Korea: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)
Figure 39. Rest of APAC: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)
Figure 40. Middle East and Africa: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)
Figure 41. Middle East and Africa: Anatomic Pathology Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 42. South Africa: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)
Figure 43. Saudi Arabia: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)
Figure 44. United Arab Emirates: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)
Figure 45. Rest of Middle East and Africa: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)
Figure 46. South and Central America: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)
Figure 47. South and Central America: Anatomic Pathology Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 48. Brazil: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)
Figure 49. Argentina: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)
Figure 50. Rest of South and Central America: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)
Figure 51. Growth Strategies in Anatomic Pathology Market
The List of Companies – Workflow Management System Market
o Appian Corp
o Bizagi
o Newgen Software Technologies Ltd.
o Nintex UK Ltd
o Oracle Corp
o Kissflow Inc
o Zapier Inc.
o S4BT Srl
o Analysis s.r.l.
o Bizzmine
You must be logged in to post a review.
Reviews
There are no reviews yet.